The role of refugee and migrant migration status on medication adherence: Mediation through illness perceptions


Autoři: Wejdan Shahin aff001;  Gerard A. Kennedy aff001;  Wendell Cockshaw aff001;  Ieva Stupans aff001
Působiště autorů: School of Health & Biomedical Sciences, RMIT University, Bundoora, Victoria, Australia aff001
Vyšlo v časopise: PLoS ONE 15(1)
Kategorie: Research Article
prolekare.web.journal.doi_sk: 10.1371/journal.pone.0227326

Souhrn

Background

Illness perceptions may vary between different populations. This raises the question as to whether refugees and migrants of the same ethnic background have different perceptions. Understanding differences may have a significant impact on enhancing medication adherence in these groups.

Objective

The study examined the associations and differences between illness perceptions, and medication adherence in hypertensive Middle Eastern migrants and refugees.

Methods

Middle Eastern refugees and migrants (≥30 years old), with hypertension were recruited from Arabic community groups in Australia and asked to complete a cross-sectional survey. The survey consisted of basic socio-demographic and clinical profile, self-reported illness perceptions, and self-reported medication adherence. The outcome measure was the Medication Adherence Questionnaire. Simple mediation modelling was applied to examine the role of illness perceptions as a mediator between different migration statuses, and medication adherence.

Results

A total of 320 participants were recruited; 168 refugees, and 152 migrants. Educational level was found to be positively significantly associated with medication adherence in refugees, p = 0.003, while employed migrants were more likely to report higher adherence to hypertensive medication, p = 0.005. In both groups, there was a significant association between illness perceptions and medication adherence p = 0.0001. Significant differences were found between both groups regarding adherence and illness perceptions variables. Refugees had more negative illness perceptions and were less adherent than migrants. Illness perception was a mediator in the relationship between migration status and medication adherence; the unstandardized indirect effect was 0.24, and the 95% confidence interval ranged from (0.21–0.36).

Conclusions

To achieve better adherence to medications in vulnerable populations such as refugees, illness perceptions need to be understood, and differentiated from other populations, such as migrants from similar backgrounds. Patients’ education about illnesses and medications should be specific and targeted to each population. Interventional studies are recommended to modify refugees’ and migrants’ illness perceptions, to enhance medication adherence and wellbeing.

Klíčová slova:

Allied health care professionals – Australia – Behavioral and social aspects of health – Culture – Diabetes mellitus – Hypertension – Medical education – Questionnaires


Zdroje

1. Chen S, Tsai J, Chou K. Illness perceptions and adherence to therapeutic regimens among patients with hypertension: a structural modeling approach. Int J Nurs Stud. 2011;48(2):235–45. doi: 10.1016/j.ijnurstu.2010.07.005 20678768. Language: English. Entry Date: 20110329. Revision Date: 20150711. Publication Type: Journal Article.

2. Hsiao C- Y, Chang C, Chen C-D. An investigation on illness perception and adherence among hypertensive patients. Kaohsiung J Med Sci. 2012;28(8):442–7. doi: 10.1016/j.kjms.2012.02.015 22892166

3. Saarti S, Hajj A, Karam L, Jabbour H, Sarkis A, El Osta N, et al. Association between adherence, treatment satisfaction and illness perception in hypertensive patients. J Hum Hypertens. 2016;30(5):341–5. doi: 10.1038/jhh.2015.86 26310182

4. Holmes EAF, Hughes DA, Morrison VL. Predicting Adherence to Medications Using Health Psychology Theories: A Systematic Review of 20 Years of Empirical Research. Value in Health. 2014;17(8):863–76. doi: 10.1016/j.jval.2014.08.2671 25498782

5. Kucukarslan SN. A review of published studies of patients’ illness perceptions and medication adherence: Lessons learned and future directions. Res Social Adm Pharm. 2012;8(5):371–82. doi: 10.1016/j.sapharm.2011.09.002 22986176

6. Mathes T, Jaschinski T, Pieper D. Adherence influencing factors–a systematic review of systematic reviews. Archives of Public Health. 2014;72(1):37. doi: 10.1186/2049-3258-72-37 25671110

7. Vrijens B, Antoniou S, Burnier M, de la Sierra A, Volpe M. Current Situation of Medication Adherence in Hypertension. Front Pharmacol. 2017;8:100–. doi: 10.3389/fphar.2017.00100 28298894.

8. Shahin W, Kennedy G, Stupans I. The impact of personal and cultural beliefs on medication adherence of patients with chronic illnesses: a systematic review. Patient Prefer Adherence. 2019;Volume 13:1019–35. doi: 10.2147/PPA.S212046 31303749

9. Good BJ. The heart of what's the matter. The semantics of illness in Iran. Culture, medicine and psychiatry. 1977;1(1):25–58. Epub 1977/04/01. doi: 10.1007/bf00114809 756353.

10. Kucukarslan SN. A review of published studies of patients’ illness perceptions and medication adherence: Lessons learned and future directions. Research in Social and Administrative Pharmacy. 2012;8(5):371–82. doi: 10.1016/j.sapharm.2011.09.002 22986176

11. Leventhal H, Diefenbach M, Leventhal E. Illness cognition: Using common sense to understand treatment adherence and affect cognition interactions. Cognit Ther Res. 1992;16(2):143–63. doi: 10.1007/BF01173486

12. Moss-Morris R, Weinman J, Petrie K, Horne R, Cameron L, Buick D. The Revised Illness Perception Questionnaire (IPQ-R). Psychology & Health. 2002;17(1):1–16. doi: 10.1080/08870440290001494

13. Parliament of Australia. Refugee resettlement to Australia: what are the facts?: Parliament of Australia; 2016 [cited 2019 08 July]. Available from: https://www.aph.gov.au/About_Parliament/Parliamentary_Departments/Parliamentary_Library/pubs/rp/rp1617/RefugeeResettlement#_Toc461022121.

14. Fábos A. Refugees in the Arab Middle East: Academic and Policy Perspectives. Domes. 2015;24(1):96–110. doi: 10.1111/dome.12056

15. Kinzie JD, Riley C, McFarland B, Hayes M, Boehnlein J, Leung P, et al. High prevalence rates of diabetes and hypertension among refugee psychiatric patients. The Journal of nervous and mental disease. 2008;196(2):108–12. Epub 2008/02/16. doi: 10.1097/NMD.0b013e318162aa51 18277218.

16. Pavli A, Maltezou H. Health problems of newly arrived migrants and refugees in Europe. J Travel Med. 2017;24(4). doi: 10.1093/jtm/tax016 28426115

17. Matlin SA, Depoux A, Schütte S, Flahault A, Saso L. Migrants’ and refugees’ health: towards an agenda of solutions. Public Health Reviews. 2018;39(1):27. doi: 10.1186/s40985-018-0104-9

18. Kabir R, Misajon R, Bliuc A- M, Chambers R. Experiences of perceived exclusion by migrants and refugees in Australia. International Journal of Psychology. 2016;51.

19. Shahin W, Stupans I, Kennedy G. Health beliefs and chronic illnesses of refugees: a systematic review. Ethn Health. 2018:1–13. doi: 10.1080/13557858.2018.1557118 30537853

20. Bjertrup PJ, Bouhenia M, Mayaud P, Perrin C, Ben Farhat J, Blanchet K. A life in waiting: Refugees' mental health and narratives of social suffering after European Union border closures in March 2016. Social Science & Medicine. 2018;215:53–60. doi: https://doi.org/10.1016/j.socscimed.2018.08.040.

21. Hocking DC, Kennedy GA, Sundram S. Social factors ameliorate psychiatric disorders in community-based asylum seekers independent of visa status. Psychiatry Research. 2015;230(2):628–36. doi: 10.1016/j.psychres.2015.10.018 26518226

22. Al Samaraie NA. Humanitarian implications of the wars in Iraq. International Review of the Red Cross. 2007;89(868):929–42.

23. Al Qasem A, Smith F, Clifford S. Adherence to medication among chronic patients in Middle Eastern countries: review of studies. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit. 2011;17(4):356–63.

24. Alzubaidi H, Mc Narmara K, Kilmartin GM, Kilmartin JF, Marriott J. The relationships between illness and treatment perceptions with adherence to diabetes self-care: A comparison between Arabic-speaking migrants and Caucasian English-speaking patients. Diabetes Res Clin Pract. 2015;110(2):208–17. doi: 10.1016/j.diabres.2015.08.006 26415673

25. Ashur ST, Shah SA, Bosseri S, Morisky DE, Shamsuddin K. Illness perceptions of libyans with t2dm and their influence on medication adherence: A study in a diabetes center in tripoli. Libyan J Med. 2015;10. doi: 10.3402/ljm.v10.29797 26714569

26. Australian Institute of Health and Welfare. Australia's health 2016: Australian Institute of Health and Welfare; 2016 [cited 2019 03 October 2019]. Available from: https://www.aihw.gov.au/getmedia/666de2ad-1c92-4db3-9c01-1368ba3c8c98/ah16-3-3-chronic-disease-comorbidities.pdf.aspx.

27. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74. Epub 1986/01/01. doi: 10.1097/00005650-198601000-00007 3945130.

28. Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. J Psychosom Res. 2006;60(6):631–7. Epub 2006/05/30. doi: 10.1016/j.jpsychores.2005.10.020 16731240.

29. Koh U, La Caze A, Cottrell N. Validated adherence scales used in a measurement-guided medication management approach to target and tailor a medication adherence intervention: A randomised controlled trial. BMJ Open. 2016;6. doi: 10.1136/bmjopen-2016-013375 27903564

30. Brooks CM, Richards JM, Kohler CL, Soong SJ, Martin B, Windsor RA, et al. Assessing adherence to asthma medication and inhaler regimens: a psychometric analysis of adult self-report scales. Medical care. 1994;32(3):298–307. Epub 1994/03/01. doi: 10.1097/00005650-199403000-00008 8145604.

31. Erickson SR, Coombs JH, Kirking DM, Azimi AR. Compliance from self-reported versus pharmacy claims data with metered-dose inhalers. The Annals of pharmacotherapy. 2001;35(9):997–1003. Epub 2001/09/28. doi: 10.1345/aph.10379 11573875.

32. Khan MU, Shah S, Hameed T. Barriers to and determinants of medication adherence among hypertensive patients attended National Health Service Hospital, Sunderland. J Pharm Bioallied Sci. 2014;6(2):104–8. doi: 10.4103/0975-7406.129175 24741278.

33. Morisky DE, Green LW, Levine DM. Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence. Medical Care. 1986;24(1):67–74. PubMed PMID: 00005650-198601000-00007. doi: 10.1097/00005650-198601000-00007 3945130

34. Broadbent E, Wilkes C, Koschwanez H, Weinman J, Norton S, Petrie KJ. A systematic review and meta-analysis of the Brief Illness Perception Questionnaire. Psychology & Health. 2015;30(11):1361–85. doi: 10.1080/08870446.2015.1070851 26181764

35. WebMD. Causes of high blood pressure: WebMD; 2017 [cited 2019 22/07/2019]. Available from: https://www.webmd.com/hypertension-high-blood-pressure/guide/blood-pressure-causes#1.

36. Allen M. The SAGE Encyclopedia of Communication Research Methods. Thousand Oaks, California2017.

37. Hayes AF. PROCESS: A versatile computational tool for observed variable mediation, moderation, and conditional process modeling [White paper] 2012 [04 October 2019]. Available from: http://www.afhayes.com/public/process2012.pdf.

38. Sobel ME. Some New Results on Indirect Effects and Their Standard Errors in Covariance Structure Models. Sociological Methodology. 1986;16:159–86. doi: 10.2307/270922

39. Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behavior research methods. 2008;40(3):879–91. Epub 2008/08/14. doi: 10.3758/brm.40.3.879 18697684.

40. Farmer KC. Leventhal's common-sense model and medication adherence. Res Social Adm Pharm. 2012;8(5):355–6. doi: 10.1016/j.sapharm.2012.05.013 22986174

41. Mann DM, Ponieman D, Leventhal H, Halm EA. Predictors of adherence to diabetes medications: the role of disease and medication beliefs. J Behav Med. 2009;32(3):278–84. doi: 10.1007/s10865-009-9202-y 19184390

42. Rajpura J, Nayak R. Medication adherence in a sample of elderly suffering from hypertension: Evaluating the influence of illness perceptions, treatment beliefs, and illness burden. J Manag Care Pharm. 2014;20(1):58–65. doi: 10.18553/jmcp.2014.20.1.58 24511766

43. Ku GMV, Kegels G. Knowledge, attitudes and perceptions of people with type 2 diabetes as related to self-management practices: Results of a cross-sectional study conducted in Luzon, Philippines. Chronic Illness. 2015;11(2):93–107. doi: 10.1177/1742395314538291 PubMed PMID: 1710263475; 2015-25181-002. 24907237

44. Cameron LD, Leventhal H. The self-regulation of health and illness behaviour: psychology press; 2003.

45. Chen S, Tsai J, Lee W- L. The impact of illness perception on adherence to therapeutic regimens of patients with hypertension in Taiwan. Journal of Clinical Nursing. 2009;18(15):2234–44. doi: 10.1111/j.1365-2702.2008.02706.x 19583655; 2009-10521-015.

46. Peterson C, Stunkard AJ. Personal control and health promotion. Social Science & Medicine. 1989;28(8):819–28. doi: https://doi.org/10.1016/0277-9536(89)90111-1.

47. Moss-Morris R. Symptom perceptions, illness beliefs and coping in chronic fatigue syndrome. Journal of Mental Health. 2005;14(3):223–35. doi: 10.1080/09638230500136548

48. Almoshmosh N. The role of war trauma survivors in managing their own mental conditions, Syria civil war as an example. Avicenna J Med. 2016;6(2):54–9. doi: 10.4103/2231-0770.179554 27144143.

49. Oraison H, Kennedy G. Disability and Rehabilitation The effect of social support in chronic back pain: number of treatment sessions and reported level of disability The effect of social support in chronic back pain: number of treatment sessions and reported level of disability. Disability and Rehabilitation. 2019. doi: 10.1080/09638288.2019.1668969 31564167

50. Ross S, Walker A, MacLeod MJ. Patient compliance in hypertension: role of illness perceptions and treatment beliefs. J Hum Hypertens. 2004;18(9):607–13. doi: 10.1038/sj.jhh.1001721 15029218

51. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens. 1997;10(7):697–704.

52. Daugherty SL, Masoudi FA, Ellis JL, Ho PM, Schmittdiel JA, Tavel HM, et al. Age dependent gender differences in hypertension management. J Hypertens. 2011;29(5):1005. doi: 10.1097/HJH.0b013e3283449512 21330934

53. Corsonello A, Pedone C, Garasto S, Maiuri G, Carelli A, Zottola C, et al. The impact of comorbidity on medication adherence and therapeutic goals. BMC Geriatr. 2010;10(Suppl 1):L21–L. doi: 10.1186/1471-2318-10-S1-L21 PubMed PMID: PMC3290261.

54. Dent E, Toki D, Dupuis N, Marquis J, Suyeshkumar T, Benlamri M. Healthcare systems within the Middle East. Univ West Ont Med J. 2017;86(2).

55. Hahn RA, Truman BI. Education Improves Public Health and Promotes Health Equity. Int J Health Serv. 2015;45(4):657–78. Epub 2015/05/19. doi: 10.1177/0020731415585986 25995305.

56. Jeffreys MR. Clinical Nurse Specialists as Cultural Brokers, Change Agents, and Partners in Meeting the Needs of Culturally Diverse Populations. Journal of Multicultural Nursing & Health. 2005;11(2):41–8. 220298743.

57. mez-de-Regil L. Causal Attribution and Illness Perception: A Cross-Sectional Study in Mexican Patients with Psychosis. The Scientific World Journal. 2014;2014:7. doi: 10.1155/2014/969867 25525628

58. Spinks H. Australia's Migration Program: Parliament of Australia; 2010 [cited 2019 5/08/2019]. Available from: https://www.aph.gov.au/About_Parliament/Parliamentary_Departments/Parliamentary_Library/pubs/BN/1011/AustMigration#_Toc274128797.

59. Carter KL, Bonanni S. Role of the pharmacist in refugee health. American Journal of Health-System Pharmacy. 2019;76(6):403–6. doi: 10.1093/ajhp/zxy011 31361836


Článok vyšiel v časopise

PLOS One


2020 Číslo 1

Najčítanejšie v tomto čísle

Tejto téme sa ďalej venujú…


Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Význam nutraceutik u kardiovaskulárních onemocnění
nový kurz
Autori:

Faktory ovlivňující léčbu levotyroxinem

Kurz originály vs. generika

Autori: MUDr. Petr Výborný, CSc., FEBO

Autori: MUDr. Jiří Horažďovský, Ph.D

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Nemáte účet?  Registrujte sa

Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa